![Michael Klobuchar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Klobuchar
Geschäftsführer bei
EIKON THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.09.2026
Profil
Michael A. Klobuchar is currently an Independent Director at Revvity, Inc. and Chief Operating Officer at Eikon Therapeutics, Inc., both positions starting in 2024.
Former jobs include CFO, SVP & Head-Portfolio and Alliance Management at Merck Research Laboratories Massachusetts LLC, President at Merck Global Health Innovation Fund LLC, and Chief Strategy Officer & Executive Vice President at Merck & Co., Inc. Education includes graduate studies at Rutgers State University of New Jersey, undergraduate studies at Purdue University, and an MBA from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REVVITY, INC. 0.01% | 07.05.2026 | 7’368 ( 0.01% ) | 1 Mio $ | 30.09.2026 |
| 02.03.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
Aktive Positionen von Michael Klobuchar
| Unternehmen | Position | Beginn |
|---|---|---|
| REVVITY, INC. | Direktor/Vorstandsmitglied | 01.02.2024 |
| EIKON THERAPEUTICS, INC. | Geschäftsführer | 01.01.2024 |
Ehemalige bekannte Positionen von Michael Klobuchar
| Unternehmen | Position | Ende |
|---|---|---|
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Finanzdirektor/CFO | - |
Merck Global Health Innovation Fund LLC
 Merck Global Health Innovation Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Präsident | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Ausbildung von Michael Klobuchar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company that dedicated to inventing and developing of breakthrough therapeutics | Health Technology |
